Literature DB >> 20041895

Nosocomial outbreak of VIM-2 metallo-β-lactamase-producing Pseudomonas aeruginosa associated with retrograde urography.

J Elias1, C Schoen, G Heinze, G Valenza, E Gerharz, H Gerharz, U Vogel.   

Abstract

Pseudomonas aeruginosa is well adapted to the hospital setting and can cause a wide array of nosocomial infections that occasionally culminate in recalcitrant outbreaks. In the present study, we describe the first nosocomial outbreak of infection caused by bla(VIM-2)-positive P. aeruginosa in Germany. In November and December 2007, highly resistant P. aeruginosa isolates were recovered from the urine of 11 patients in the Department of Urology of a University Hospital. Bacterial isolates were typed by multilocus sequence typing and screened for known metallo-β-lactamase (MBL) genes by PCR. Environmental sources of transmission were tested for bacterial contamination using surveillance cultures. Furthermore, a matched case-control study was performed in search of medical procedures significantly associated with case status. Typing of recovered isolates confirmed VIM-2 MBL-producing P. aeruginosa of sequence type 175 in all cases. Surveillance cultures did not lead to the identification of an environmental source of the outbreak strain. Case-control analysis revealed retrograde urography as the only exposure significantly associated with case status. The analyses suggest the transmission of a single clone of VIM-2 MBL-producing P. aeruginosa leading to the infection of 11 patients within 47 days. Events in temporal proximity to retrograde urographies appear to have facilitated infection in the majority of cases. Department-specific infection control measures, including reinforced hygiene procedures during retrograde urography, quickly terminated the outbreak.
© 2010 The Authors. Journal Compilation © 2010 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20041895     DOI: 10.1111/j.1469-0691.2009.03146.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  15 in total

1.  First survey of metallo-beta-lactamases in clinical isolates of Pseudomonas aeruginosa in a German university hospital.

Authors:  Giuseppe Valenza; Biju Joseph; Johannes Elias; Heike Claus; Anett Oesterlein; Kathrin Engelhardt; Doris Turnwald; Matthias Frosch; Marianne Abele-Horn; Christoph Schoen
Journal:  Antimicrob Agents Chemother       Date:  2010-05-24       Impact factor: 5.191

2.  Identification and characterization of an unusual metallo-β-lactamase from Serratia proteamaculans.

Authors:  Peter Vella; Manfredi Miraula; Emer Phelan; Eleanor W W Leung; Fernanda Ely; David L Ollis; Ross P McGeary; Gerhard Schenk; Nataša Mitić
Journal:  J Biol Inorg Chem       Date:  2013-08-28       Impact factor: 3.358

3.  Matrix-assisted laser desorption ionization-time of flight mass spectrometry identifies Pseudomonas aeruginosa high-risk clones.

Authors:  Nadège Cabrolier; Marlène Sauget; Xavier Bertrand; Didier Hocquet
Journal:  J Clin Microbiol       Date:  2015-02-04       Impact factor: 5.948

4.  Wide dispersion of ST175 clone despite high genetic diversity of carbapenem-nonsusceptible Pseudomonas aeruginosa clinical strains in 16 Spanish hospitals.

Authors:  María García-Castillo; Rosa Del Campo; María Isabel Morosini; Elena Riera; Gabriel Cabot; Rob Willems; Rosa van Mansfeld; Antonio Oliver; Rafael Cantón
Journal:  J Clin Microbiol       Date:  2011-06-22       Impact factor: 5.948

5.  Most multidrug-resistant Pseudomonas aeruginosa isolates from hospitals in eastern France belong to a few clonal types.

Authors:  Pascal Cholley; Michelle Thouverez; Didier Hocquet; Nathalie van der Mee-Marquet; Daniel Talon; Xavier Bertrand
Journal:  J Clin Microbiol       Date:  2011-05-18       Impact factor: 5.948

6.  Dissemination of high-risk clones of extensively drug-resistant Pseudomonas aeruginosa in colombia.

Authors:  Adriana Correa; Rosa Del Campo; Marcela Perenguez; Victor M Blanco; Mercedes Rodríguez-Baños; Federico Perez; Juan J Maya; Laura Rojas; Rafael Cantón; Cesar A Arias; Maria V Villegas
Journal:  Antimicrob Agents Chemother       Date:  2015-01-20       Impact factor: 5.191

7.  Multilocus sequence typing reveals genetic diversity of carbapenem- or ceftazidime-nonsusceptible Pseudomonas aeruginosa in China.

Authors:  Jingshu Ji; Jie Wang; Zhihui Zhou; Haiping Wang; Yan Jiang; Yunsong Yu
Journal:  Antimicrob Agents Chemother       Date:  2013-08-12       Impact factor: 5.191

8.  Dissemination of VIM-2 producing Pseudomonas aeruginosa ST233 at tertiary care hospitals in Egypt.

Authors:  Mai Mahmoud Zafer; Mohamed Hamed Al-Agamy; Hadir Ahmed El-Mahallawy; Magdy Aly Amin; Seif El Din Ashour
Journal:  BMC Infect Dis       Date:  2015-03-12       Impact factor: 3.090

9.  VIM-2-producing multidrug-resistant Pseudomonas aeruginosa ST175 clone, Spain.

Authors:  Esther Viedma; Carlos Juan; Jennifer Villa; Laura Barrado; M Angeles Orellana; Francisca Sanz; Joaquín R Otero; Antonio Oliver; Fernando Chaves
Journal:  Emerg Infect Dis       Date:  2012-08       Impact factor: 6.883

10.  Antimicrobial resistance pattern and their beta-lactamase encoding genes among Pseudomonas aeruginosa strains isolated from cancer patients.

Authors:  Mai M Zafer; Mohamed H Al-Agamy; Hadir A El-Mahallawy; Magdy A Amin; Mohammed Seif El-Din Ashour
Journal:  Biomed Res Int       Date:  2014-02-23       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.